Journals / Erciyes Üniversitesi Veteriner Fakültesi Dergisi / 2014 / Cilt: 11 - Sayı: 2

The Effective and Safe use of Nonsteroidal Antiinflammatory Drugs in Dogs and Cats

Nonsteroidal Antiinflamatuvar İlaçların Kedi ve Köpeklerde Etkili ve Güvenli Kullanımı

Pages
137–143
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Inthis review, some clinically important anti-inflammatory drugs will be evaluated in terms of their effective and safe usein cats and dogs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Non-Steroidal Anti-Inflammatory Drugs (NSAID) are commonly used in veterinary medicine because oftheir analgesic, antipyretic, anti-inflammatory effects in addition to their anti-rheumatic effects.
📊
Key Findings & Data:Three primary forms of COX have been identified as COX-1, COX-2 andCOX-3.
💡
Conclusion & Impact:Inthis review, some clinically important anti-inflammatory drugs will be evaluated in terms of their effective and safe usein cats and dogs.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kedi · köpek · nonsteroidal antiinflamatuvar ilaç

Abstract

Non-Steroidal Anti-Inflammatory Drugs (NSAID) are commonly used in veterinary medicine because oftheir analgesic, antipyretic, anti-inflammatory effects in addition to their anti-rheumatic effects. Despite differences inchemical structures of the NSAID, these compounds share the effect of inhibiting the production of prostoglandins bytargeting the cyclooxygenase (COX) pathway. Three primary forms of COX have been identified as COX-1, COX-2 andCOX-3. The NSAIDs reduce the production of prostoglandins causing inflamation by inhibitting the COX-1 and COX-2 enzymes in different levels. Depending on the use of NSAIDs, severe organ dysfunctions may occur. The clinicaladverse effects associated with NSAID administration are observed more often in dogs and cats than other animals. Inthis review, some clinically important anti-inflammatory drugs will be evaluated in terms of their effective and safe usein cats and dogs.

Özet

Nonsteroidal antiinflamatuvar ilaçların (NSAİİ) ağrı kesici, ateş düşürücü, yangı önleyici etkilerinin yanında antiromatizmaletkilerinin de olması nedeniyle veteriner hekimlikte kullanımı oldukça yaygındır. NSAİİ’ların kimyasal yapılarıbirbirinden farklı olmasına rağmen, prostoglandinlerin üretimine aracılık eden siklooksijenaz enzimini (COX) inhibe edereketkinlik gösterirler. COX enzimi COX-1, COX-2 ve COX-3 olmak üzere üçe ayrılmaktadır. NSAİİ’lar COX-1 ve COX-2’yifarklı derecelerde inhibe ederek yangıya yol açan prostaglandinlerin üretimini azaltırlar. NSAİİ’ların kullanılmasına bağlıolarak şiddetli organ disfonksiyonları ile sonuçlanabilen bozukluklar oluşabilir. NSAİİ’ların istenmeyen yan etkilerindenkedi ve köpeklerin diğer hayvan türlerinden daha fazla etkilendiği belirtilmektedir. Bu kapsamda klinik açıdan önemlibazı yangı önleyici ilaçların kedi ve köpeklerde etkili ve güvenli kullanımı değerlendirilecektir.

🔖

Cite This Article

BOYACIOĞLU, M., KARADEMİR, Ü. (2022). The Effective and Safe use of Nonsteroidal Antiinflammatory Drugs in Dogs and Cats. Erciyes Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 11 - Sayı: 2, 137–143. https://ajindex.com/articles/503907

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Abacıoğlu N. Aljezi, yangı, pirezis ve nonsteroidal analjezik antiinflamatuvar ilaçlar. Bökesoy, A., Çakıç, İ., Melli, M. eds. In: Farmakoloji Ders Kitabı. Ankara: Türk Farmakoloji Derneği, 2000; pp. 473-95
  2. Adams HR. Nonnarcotic analgesics. Booth N.H., McDonald L.E. eds. In: Veterinary Pharmacology and Therapeutics, 8th edition, Iowa State Universty Press, 2001; pp. 329-63
  3. Aspirin. http://www.elephantcare.org/Drugs/aspirin.htm. Erişim tarihi: 05.12.2013
  4. Brideau C, Van Staden C, Chan CC. Invitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats. Am J Vet Res 2001; 62(11):1755-60
  5. Clark TP, Chieffo C, Huhn JC, Nimz EL, Wang C, Boy MG. The steady-state pharmacokinetics and bioequivalence of carprofen administered orally and subcutaneously in dogs. J Vet Pharmacol Ther 2003; 26(3): 187-92
  6. Curry SL, Cogar SM, Cook JL. Nonsteroidal antiinflammatory drugs: A review. J Am An Hos Assoc 2005; 41(5): 298-309
  7. Doig PA, Purbrick KA, Hare JE, McKeown DB. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis. Can Vet J 2000; 41: 296-300
  8. EMEA.www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500014270.pdf; Erişim tarihi:08.01.2013
  9. FDA.http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/DrugLabels/UCM050403.pdf; Erişim tarihi:08.01.2013
  10. Gannong FW. Tıbbi Fizyoloji, 19.baskıdan çeviri. Ankara: Barıs Kitapevi, 1999; p. 550-2
  11. Gierse JK, Staten NR, Casperson GF, Koboldt CM, Trigg JS, Reitz BA, Pierce JL, Seibert K. Cloning, expression and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2. Vet Therapeutics 2002; 3(3): 270-80
  12. Homer LM, Clarke CR, Weingarten AJ. Effect of dietary fat on oral bioavailability of tepoxalin in dogs. J Vet Pharmacol Therap 2005; 28(3): 287-91
  13. Karol AM. Non-steroidal anti-inflammatory analgesics: a review of current practice. J Vet Emerg and Critic Care 2002; 12(2): 89-97
  14. Karol AM. Non-steroidal anti-inflammatory analgesics: indications and condraindicatins for pain management in dogs and cats. Vet Clin North Am Small Anim Prac 2000; 30(4):783-804
  15. Kaya S. Narkotik Olmayan Ağrı Kesiciler. Kaya S. Eds. In: Veteriner Farmakoloji
  16. Baskı. Ankara: Medisan Yayınevi, 2006; p. 295-320
  17. Kis B, Snipes JA, Busija DW. Acetaminophen and the COX-3 puzzle: sorting out facts, fictions and uncertainties. J Pharmacol Exp Ther 2005; 315(1): 1-7
  18. Knight EV, Kimb